International Flavors & Fragrances Inc. (IFF) latest updates suggest a mixed market consensus highlighted by the
average hold rating given by multiple brokerages. Recently, IFF welcomed a new board member and has inked a deal selling its
Pharma Solutions business for $2.85B. Despite revenue resilience, IFF faces challenges, as evidenced by stock performance outpacing its competitors even on loss days. Notable transactions include
Parallel Advisors LLC and
Bank of Nova Scotia holding positions worth $298,000 and $30.73 million respectively. Recent acquisitions by Norges Bank and Nomura Asset Management reflect institutional interest. Earnings have been inconsistent, with Q1 showing a beat despite sales dip, but Q3 and Q4 reporting losses. IFF's
debt risk has been a concern, along with a reduction in dividends, causing certain financial groups such as PNC Financial Services Group Inc. to cut their holdings. The company is now focused on vegan supplements and unexpectedly, the price target has been raised to $110. A SWOT analysis suggests a conflicted outlook with high shareholder return risks.
International Flavors Fragrances IFF News Analytics from Fri, 01 Sep 2023 07:00:00 GMT to Sun, 02 Jun 2024 13:55:10 GMT -
Rating 0
- Innovation -6
- Information 2
- Rumor -4
